Insider Transactions in Q4 2021 at Adtran Inc (ADTN)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 31
2021
|
H Fenwick Huss |
BUY
Grant, award, or other acquisition
|
Direct |
3,943
+6.54%
|
-
|
Dec 31
2021
|
H Fenwick Huss |
SELL
Sale (or disposition) back to the issuer
|
Direct |
0
|
$0
$22.83 P/Share
|
Dec 31
2021
|
H Fenwick Huss |
BUY
Exercise of conversion of derivative security
|
Direct |
114
+0.22%
|
-
|
Dec 31
2021
|
Gregory James Mc Cray |
BUY
Grant, award, or other acquisition
|
Direct |
3,943
+9.91%
|
-
|
Dec 31
2021
|
Gregory James Mc Cray |
SELL
Sale (or disposition) back to the issuer
|
Direct |
0
|
$0
$22.83 P/Share
|
Dec 31
2021
|
Gregory James Mc Cray |
BUY
Exercise of conversion of derivative security
|
Direct |
114
+0.36%
|
-
|
Dec 31
2021
|
Balan Nair |
BUY
Grant, award, or other acquisition
|
Direct |
3,943
+5.05%
|
-
|
Dec 31
2021
|
Balan Nair |
SELL
Sale (or disposition) back to the issuer
|
Direct |
0
|
$0
$22.83 P/Share
|
Dec 31
2021
|
Balan Nair |
BUY
Exercise of conversion of derivative security
|
Direct |
114
+0.16%
|
-
|
Dec 31
2021
|
Hourigan Rice Jacqueline |
BUY
Grant, award, or other acquisition
|
Direct |
3,943
+50.0%
|
-
|
Dec 31
2021
|
Hourigan Rice Jacqueline |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
0
|
$0
$22.83 P/Share
|
Dec 31
2021
|
Hourigan Rice Jacqueline |
BUY
Exercise of conversion of derivative security
|
Indirect |
114
+0.27%
|
-
|
Dec 31
2021
|
Hourigan Rice Jacqueline |
BUY
Other acquisition or disposition
|
Indirect |
6,094
+12.85%
|
-
|
Dec 31
2021
|
Hourigan Rice Jacqueline |
SELL
Other acquisition or disposition
|
Direct |
6,094
-100.0%
|
-
|
Dec 31
2021
|
Kathryn A Walker |
BUY
Grant, award, or other acquisition
|
Direct |
3,943
+7.67%
|
-
|
Dec 31
2021
|
Kathryn A Walker |
SELL
Sale (or disposition) back to the issuer
|
Direct |
0
|
$0
$22.83 P/Share
|
Dec 31
2021
|
Kathryn A Walker |
BUY
Exercise of conversion of derivative security
|
Direct |
114
+0.26%
|
-
|
Dec 03
2021
|
Michael Foliano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37
+0.07%
|
$777
$21.1 P/Share
|
Nov 30
2021
|
Robert Conger SVP, Technology & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.09%
|
$340
$20.83 P/Share
|
Nov 30
2021
|
Michael Foliano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
1
+0.41%
|
$18
$18.55 P/Share
|
Nov 30
2021
|
Ray Harris Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3
+0.02%
|
$60
$20.83 P/Share
|
Nov 30
2021
|
Marc Kimpe SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.09%
|
$480
$20.83 P/Share
|
Nov 30
2021
|
Thomas R Stanton Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
223
+0.07%
|
$4,683
$21.09 P/Share
|
Nov 30
2021
|
Gregory James Mc Cray |
BUY
Grant, award, or other acquisition
|
Direct |
32
+0.1%
|
$672
$21.09 P/Share
|
Nov 30
2021
|
Eduard Scheiterer SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
74
+0.18%
|
$1,554
$21.09 P/Share
|
Nov 30
2021
|
James Denson Wilson Jr Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
91
+0.17%
|
$1,911
$21.09 P/Share
|
Nov 30
2021
|
James Denson Wilson Jr Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
17
+0.41%
|
$306
$18.55 P/Share
|
Nov 30
2021
|
Ronald Centis SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.05%
|
$240
$20.83 P/Share
|
Nov 17
2021
|
Thomas R Stanton Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,253
+9.03%
|
-
|
Nov 17
2021
|
Ronald Centis SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
5,251
+16.88%
|
-
|
Nov 17
2021
|
Robert Conger SVP, Technology & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
4,300
+19.25%
|
-
|
Nov 17
2021
|
Michael Foliano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,258
+11.86%
|
-
|
Nov 17
2021
|
Marc Kimpe SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+13.33%
|
-
|
Nov 17
2021
|
Eduard Scheiterer SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
8,259
+17.13%
|
-
|
Nov 17
2021
|
James Denson Wilson Jr Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,588
+13.32%
|
-
|
Nov 17
2021
|
Ray Harris Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,215
+20.01%
|
-
|
Nov 16
2021
|
Ray Harris Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-3.16%
|
$8,652
$21.9 P/Share
|
Nov 16
2021
|
Thomas R Stanton Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,059
-1.1%
|
$64,239
$21.66 P/Share
|
Nov 16
2021
|
James Denson Wilson Jr Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
659
-1.67%
|
$13,839
$21.66 P/Share
|
Nov 16
2021
|
Michael Foliano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
874
-2.16%
|
$18,354
$21.66 P/Share
|
Nov 16
2021
|
Marc Kimpe SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
436
-1.84%
|
$9,156
$21.66 P/Share
|
Nov 16
2021
|
Robert Conger SVP, Technology & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
444
-3.13%
|
$9,324
$21.66 P/Share
|
Nov 16
2021
|
Ronald Centis SVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
544
-2.57%
|
$11,424
$21.66 P/Share
|
Nov 15
2021
|
Thomas R Stanton Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,062
-1.44%
|
$85,302
$21.42 P/Share
|
Nov 15
2021
|
James Denson Wilson Jr Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
901
-2.24%
|
$18,921
$21.42 P/Share
|
Nov 15
2021
|
Michael Foliano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
888
-2.15%
|
$18,648
$21.42 P/Share
|
Nov 15
2021
|
Ray Harris Chief Information Officer |
SELL
Open market or private sale
|
Direct |
2,270
-14.82%
|
$47,670
$21.23 P/Share
|
Nov 15
2021
|
Marc Kimpe SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
573
-2.37%
|
$12,033
$21.42 P/Share
|
Nov 15
2021
|
Robert Conger SVP, Technology & Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
209
-1.45%
|
$4,389
$21.42 P/Share
|
Nov 15
2021
|
Ronald Centis SVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
726
-3.32%
|
$15,246
$21.42 P/Share
|